The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset
about
Predicting disease progression in amyotrophic lateral sclerosis.Predicting functional decline and survival in amyotrophic lateral sclerosis.Assessment of Motor Units in Neuromuscular Disease.Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis.Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor.Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.Imaging muscle as a potential biomarker of denervation in motor neuron disease.Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort.A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis.Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression.Disease progression in C9orf72 mutation carriers.Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients.
P2860
Q30490321-4518A303-BCB2-45A2-BABD-A0E9735A7913Q33562655-E3D0AB64-9829-45E6-9AEE-60A5B19E1B3AQ38947718-20B3417A-11DE-4811-88B2-A0A62BDFE5A0Q38983572-623FCB93-1708-41A1-AC69-9F1B95E1E481Q45229341-635A2ECA-026C-44E9-B70B-8B78DF35E2BDQ47136854-3F560E6C-49CB-4AD7-B70F-5B7D47D31AD5Q47624980-FE861246-A03C-4F1E-99E9-281779C96582Q47680014-738AEC0D-6331-40C1-A5DC-B2F629B2A839Q47772089-8BA6D02D-DB1C-4728-B914-F71FF6E49D74Q47815494-1335715B-C471-471A-954C-0DFD340AD767Q47871387-5CD43D75-AD3E-4E51-9D72-9A3D2F1306D1Q49222007-E2881DB8-F4FE-41AB-BB09-CBF76B07F60CQ50584457-77B87751-35D4-444A-835A-E4B3D82F0B1FQ55443790-E4C0B61E-436C-4122-8DBD-F3EDA3B8FBD1
P2860
The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The ALSFRS as an outcome measu ...... relationship to symptom onset
@en
The ALSFRS as an outcome measu ...... relationship to symptom onset.
@nl
type
label
The ALSFRS as an outcome measu ...... relationship to symptom onset
@en
The ALSFRS as an outcome measu ...... relationship to symptom onset.
@nl
prefLabel
The ALSFRS as an outcome measu ...... relationship to symptom onset
@en
The ALSFRS as an outcome measu ...... relationship to symptom onset.
@nl
P2860
P50
P1476
The ALSFRS as an outcome measu ...... relationship to symptom onset
@en
P2093
Malcolm Proudfoot
P2860
P304
P356
10.3109/21678421.2016.1140786
P577
2016-02-11T00:00:00Z